PIK3CB and colorectal carcinoma: SLITRK4 has been demonstrated to accelerate CRC carcinogenesis, invasion, migration, and angiogenesis via the upregulation of the PI3K/AKT/NF‐κB pathway, alteration of the extracellular matrix, and upregulation of cytokine production.